Click for best price
Rheumatoid Arthritis Stem Cell Therapy Market Size, Share 2023
The global Rheumatoid Arthritis Stem Cell Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2035, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Rheumatoid arthritis stem cell therapy has been demonstrated to induce profound healing activity, halt arthritic conditions, and in many cases, reverse and regenerate joint tissue. Today, bone marrow transplant, adipose or fat-derived stem cells, and allogeneic mesenchymal stem cells (human umbilical cord tissue) are used for rheumatoid arthritis stem cell therapy. As the rheumatoid arthritis worsens, the body initiates autoimmune response and attacks the cells. Rheumatoid arthritis stem cell therapy is growing in popularity across hospitals, ambulatory surgical centers, and specialty clinics, as it increases the healing of joints and further treats the entire system that causes the joint pain and inflammation.
This report aims to provide a comprehensive presentation of the global market for Rheumatoid Arthritis Stem Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rheumatoid Arthritis Stem Cell Therapy. This report contains market size and forecasts of Rheumatoid Arthritis Stem Cell Therapy in global, including the following market information:
Global Rheumatoid Arthritis Stem Cell Therapy Market Revenue, 2018-2023, 2024-2035, ($ millions)
Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Allogeneic Mesenchymal Stem Cells Segment to Reach $ Million by 2035, with a % CAGR in next six years.
The global key manufacturers of Rheumatoid Arthritis Stem Cell Therapy include Mesoblast, Roslin Cells, Regeneus, ReNeuron Group, International Stem Cell Corporation and Takeda, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Rheumatoid Arthritis Stem Cell Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rheumatoid Arthritis Stem Cell Therapy Market, by Type, 2018-2023, 2024-2035 ($ millions)
Global Rheumatoid Arthritis Stem Cell Therapy Market Segment Percentages, by Type, 2022 (%)
- Allogeneic Mesenchymal Stem Cells
- Bone Marrow Transplant
- Adipose Tissue Stem Cells
Global Rheumatoid Arthritis Stem Cell Therapy Market, by Application, 2018-2023, 2024-2035 ($ millions)
Global Rheumatoid Arthritis Stem Cell Therapy Market Segment Percentages, by Application, 2022 (%)
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
Global Rheumatoid Arthritis Stem Cell Therapy Market, By Region and Country, 2018-2023, 2024-2035 ($ Millions)
Global Rheumatoid Arthritis Stem Cell Therapy Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Rheumatoid Arthritis Stem Cell Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Rheumatoid Arthritis Stem Cell Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Mesoblast
- Roslin Cells
- Regeneus
- ReNeuron Group
- International Stem Cell Corporation
- Takeda
Outline of Major Chapters:
Chapter 1: Introduces the definition of Rheumatoid Arthritis Stem Cell Therapy, market overview.
Chapter 2: Global Rheumatoid Arthritis Stem Cell Therapy market size in revenue.
Chapter 3: Detailed analysis of Rheumatoid Arthritis Stem Cell Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Rheumatoid Arthritis Stem Cell Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Rheumatoid Arthritis Stem Cell Therapy Market, Global Outlook and Forecast 2023-2035 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
68 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Rheumatoid Arthritis Stem Cell Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Rheumatoid Arthritis Stem Cell Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Rheumatoid Arthritis Stem Cell Therapy Overall Market Size
2.1 Global Rheumatoid Arthritis Stem Cell Therapy Market Size: 2022 VS 2035
2.2 Global Rheumatoid Arthritis Stem Cell Therapy Market Size, Prospects & Forecasts: 2018-2035
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Rheumatoid Arthritis Stem Cell Therapy Players in Global Market
3.2 Top Global Rheumatoid Arthritis Stem Cell Therapy Companies Ranked by Revenue
3.3 Global Rheumatoid Arthritis Stem Cell Therapy Revenue by Companies
3.4 Top 3 and Top 5 Rheumatoid Arthritis Stem Cell Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Rheumatoid Arthritis Stem Cell Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Rheumatoid Arthritis Stem Cell Therapy Players in Global Market
3.6.1 List of Global Tier 1 Rheumatoid Arthritis Stem Cell Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Rheumatoid Arthritis Stem Cell Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Rheumatoid Arthritis Stem Cell Therapy Market Size Markets, 2022 & 2035
4.1.2 Allogeneic Mesenchymal Stem Cells
4.1.3 Bone Marrow Transplant
4.1.4 Adipose Tissue Stem Cells
4.2 By Type - Global Rheumatoid Arthritis Stem Cell Therapy Revenue & Forecasts
4.2.1 By Type - Global Rheumatoid Arthritis Stem Cell Therapy Revenue, 2018-2023
4.2.2 By Type - Global Rheumatoid Arthritis Stem Cell Therapy Revenue, 2024-2035
4.2.3 By Type - Global Rheumatoid Arthritis Stem Cell Therapy Revenue Market Share, 2018-2035
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Rheumatoid Arthritis Stem Cell Therapy Market Size, 2022 & 2035
5.1.2 Hospitals
5.1.3 Ambulatory Surgical Centers
5.1.4 Specialty Clinics
5.2 By Application - Global Rheumatoid Arthritis Stem Cell Therapy Revenue & Forecasts
5.2.1 By Application - Global Rheumatoid Arthritis Stem Cell Therapy Revenue, 2018-2023
5.2.2 By Application - Global Rheumatoid Arthritis Stem Cell Therapy Revenue, 2024-2035
5.2.3 By Application - Global Rheumatoid Arthritis Stem Cell Therapy Revenue Market Share, 2018-2035
6 Sights by Region
6.1 By Region - Global Rheumatoid Arthritis Stem Cell Therapy Market Size, 2022 & 2035
6.2 By Region - Global Rheumatoid Arthritis Stem Cell Therapy Revenue & Forecasts
6.2.1 By Region - Global Rheumatoid Arthritis Stem Cell Therapy Revenue, 2018-2023
6.2.2 By Region - Global Rheumatoid Arthritis Stem Cell Therapy Revenue, 2024-2035
6.2.3 By Region - Global Rheumatoid Arthritis Stem Cell Therapy Revenue Market Share, 2018-2035
6.3 North America
6.3.1 By Country - North America Rheumatoid Arthritis Stem Cell Therapy Revenue, 2018-2035
6.3.2 US Rheumatoid Arthritis Stem Cell Therapy Market Size, 2018-2035
6.3.3 Canada Rheumatoid Arthritis Stem Cell Therapy Market Size, 2018-2035
6.3.4 Mexico Rheumatoid Arthritis Stem Cell Therapy Market Size, 2018-2035
6.4 Europe
6.4.1 By Country - Europe Rheumatoid Arthritis Stem Cell Therapy Revenue, 2018-2035
6.4.2 Germany Rheumatoid Arthritis Stem Cell Therapy Market Size, 2018-2035
6.4.3 France Rheumatoid Arthritis Stem Cell Therapy Market Size, 2018-2035
6.4.4 U.K. Rheumatoid Arthritis Stem Cell Therapy Market Size, 2018-2035
6.4.5 Italy Rheumatoid Arthritis Stem Cell Therapy Market Size, 2018-2035
6.4.6 Russia Rheumatoid Arthritis Stem Cell Therapy Market Size, 2018-2035
6.4.7 Nordic Countries Rheumatoid Arthritis Stem Cell Therapy Market Size, 2018-2035
6.4.8 Benelux Rheumatoid Arthritis Stem Cell Therapy Market Size, 2018-2035
6.5 Asia
6.5.1 By Region - Asia Rheumatoid Arthritis Stem Cell Therapy Revenue, 2018-2035
6.5.2 China Rheumatoid Arthritis Stem Cell Therapy Market Size, 2018-2035
6.5.3 Japan Rheumatoid Arthritis Stem Cell Therapy Market Size, 2018-2035
6.5.4 South Korea Rheumatoid Arthritis Stem Cell Therapy Market Size, 2018-2035
6.5.5 Southeast Asia Rheumatoid Arthritis Stem Cell Therapy Market Size, 2018-2035
6.5.6 India Rheumatoid Arthritis Stem Cell Therapy Market Size, 2018-2035
6.6 South America
6.6.1 By Country - South America Rheumatoid Arthritis Stem Cell Therapy Revenue, 2018-2035
6.6.2 Brazil Rheumatoid Arthritis Stem Cell Therapy Market Size, 2018-2035
6.6.3 Argentina Rheumatoid Arthritis Stem Cell Therapy Market Size, 2018-2035
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Revenue, 2018-2035
6.7.2 Turkey Rheumatoid Arthritis Stem Cell Therapy Market Size, 2018-2035
6.7.3 Israel Rheumatoid Arthritis Stem Cell Therapy Market Size, 2018-2035
6.7.4 Saudi Arabia Rheumatoid Arthritis Stem Cell Therapy Market Size, 2018-2035
6.7.5 UAE Rheumatoid Arthritis Stem Cell Therapy Market Size, 2018-2035
7 Rheumatoid Arthritis Stem Cell Therapy Companies Profiles
7.1 Mesoblast
7.1.1 Mesoblast Company Summary
7.1.2 Mesoblast Business Overview
7.1.3 Mesoblast Rheumatoid Arthritis Stem Cell Therapy Major Product Offerings
7.1.4 Mesoblast Rheumatoid Arthritis Stem Cell Therapy Revenue in Global Market (2018-2023)
7.1.5 Mesoblast Key News & Latest Developments
7.2 Roslin Cells
7.2.1 Roslin Cells Company Summary
7.2.2 Roslin Cells Business Overview
7.2.3 Roslin Cells Rheumatoid Arthritis Stem Cell Therapy Major Product Offerings
7.2.4 Roslin Cells Rheumatoid Arthritis Stem Cell Therapy Revenue in Global Market (2018-2023)
7.2.5 Roslin Cells Key News & Latest Developments
7.3 Regeneus
7.3.1 Regeneus Company Summary
7.3.2 Regeneus Business Overview
7.3.3 Regeneus Rheumatoid Arthritis Stem Cell Therapy Major Product Offerings
7.3.4 Regeneus Rheumatoid Arthritis Stem Cell Therapy Revenue in Global Market (2018-2023)
7.3.5 Regeneus Key News & Latest Developments
7.4 ReNeuron Group
7.4.1 ReNeuron Group Company Summary
7.4.2 ReNeuron Group Business Overview
7.4.3 ReNeuron Group Rheumatoid Arthritis Stem Cell Therapy Major Product Offerings
7.4.4 ReNeuron Group Rheumatoid Arthritis Stem Cell Therapy Revenue in Global Market (2018-2023)
7.4.5 ReNeuron Group Key News & Latest Developments
7.5 International Stem Cell Corporation
7.5.1 International Stem Cell Corporation Company Summary
7.5.2 International Stem Cell Corporation Business Overview
7.5.3 International Stem Cell Corporation Rheumatoid Arthritis Stem Cell Therapy Major Product Offerings
7.5.4 International Stem Cell Corporation Rheumatoid Arthritis Stem Cell Therapy Revenue in Global Market (2018-2023)
7.5.5 International Stem Cell Corporation Key News & Latest Developments
7.6 Takeda
7.6.1 Takeda Company Summary
7.6.2 Takeda Business Overview
7.6.3 Takeda Rheumatoid Arthritis Stem Cell Therapy Major Product Offerings
7.6.4 Takeda Rheumatoid Arthritis Stem Cell Therapy Revenue in Global Market (2018-2023)
7.6.5 Takeda Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Rheumatoid Arthritis Stem Cell Therapy Market Opportunities & Trends in Global Market
Table 2. Rheumatoid Arthritis Stem Cell Therapy Market Drivers in Global Market
Table 3. Rheumatoid Arthritis Stem Cell Therapy Market Restraints in Global Market
Table 4. Key Players of Rheumatoid Arthritis Stem Cell Therapy in Global Market
Table 5. Top Rheumatoid Arthritis Stem Cell Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Rheumatoid Arthritis Stem Cell Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Rheumatoid Arthritis Stem Cell Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Rheumatoid Arthritis Stem Cell Therapy Product Type
Table 9. List of Global Tier 1 Rheumatoid Arthritis Stem Cell Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Rheumatoid Arthritis Stem Cell Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Rheumatoid Arthritis Stem Cell Therapy Revenue, (US$, Mn), 2022 & 2035
Table 12. By Type - Rheumatoid Arthritis Stem Cell Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Rheumatoid Arthritis Stem Cell Therapy Revenue in Global (US$, Mn), 2024-2035
Table 14. By Application ? Global Rheumatoid Arthritis Stem Cell Therapy Revenue, (US$, Mn), 2022 & 2035
Table 15. By Application - Rheumatoid Arthritis Stem Cell Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Rheumatoid Arthritis Stem Cell Therapy Revenue in Global (US$, Mn), 2024-2035
Table 17. By Region ? Global Rheumatoid Arthritis Stem Cell Therapy Revenue, (US$, Mn), 2022 & 2035
Table 18. By Region - Global Rheumatoid Arthritis Stem Cell Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Rheumatoid Arthritis Stem Cell Therapy Revenue (US$, Mn), 2024-2035
Table 20. By Country - North America Rheumatoid Arthritis Stem Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Rheumatoid Arthritis Stem Cell Therapy Revenue, (US$, Mn), 2024-2035
Table 22. By Country - Europe Rheumatoid Arthritis Stem Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Rheumatoid Arthritis Stem Cell Therapy Revenue, (US$, Mn), 2024-2035
Table 24. By Region - Asia Rheumatoid Arthritis Stem Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Rheumatoid Arthritis Stem Cell Therapy Revenue, (US$, Mn), 2024-2035
Table 26. By Country - South America Rheumatoid Arthritis Stem Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Rheumatoid Arthritis Stem Cell Therapy Revenue, (US$, Mn), 2024-2035
Table 28. By Country - Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Revenue, (US$, Mn), 2024-2035
Table 30. Mesoblast Company Summary
Table 31. Mesoblast Rheumatoid Arthritis Stem Cell Therapy Product Offerings
Table 32. Mesoblast Rheumatoid Arthritis Stem Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Mesoblast Key News & Latest Developments
Table 34. Roslin Cells Company Summary
Table 35. Roslin Cells Rheumatoid Arthritis Stem Cell Therapy Product Offerings
Table 36. Roslin Cells Rheumatoid Arthritis Stem Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Roslin Cells Key News & Latest Developments
Table 38. Regeneus Company Summary
Table 39. Regeneus Rheumatoid Arthritis Stem Cell Therapy Product Offerings
Table 40. Regeneus Rheumatoid Arthritis Stem Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Regeneus Key News & Latest Developments
Table 42. ReNeuron Group Company Summary
Table 43. ReNeuron Group Rheumatoid Arthritis Stem Cell Therapy Product Offerings
Table 44. ReNeuron Group Rheumatoid Arthritis Stem Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. ReNeuron Group Key News & Latest Developments
Table 46. International Stem Cell Corporation Company Summary
Table 47. International Stem Cell Corporation Rheumatoid Arthritis Stem Cell Therapy Product Offerings
Table 48. International Stem Cell Corporation Rheumatoid Arthritis Stem Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. International Stem Cell Corporation Key News & Latest Developments
Table 50. Takeda Company Summary
Table 51. Takeda Rheumatoid Arthritis Stem Cell Therapy Product Offerings
Table 52. Takeda Rheumatoid Arthritis Stem Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Takeda Key News & Latest Developments
List of Figures
Figure 1. Rheumatoid Arthritis Stem Cell Therapy Segment by Type in 2022
Figure 2. Rheumatoid Arthritis Stem Cell Therapy Segment by Application in 2022
Figure 3. Global Rheumatoid Arthritis Stem Cell Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Rheumatoid Arthritis Stem Cell Therapy Market Size: 2022 VS 2035 (US$, Mn)
Figure 6. Global Rheumatoid Arthritis Stem Cell Therapy Revenue, 2018-2035 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Rheumatoid Arthritis Stem Cell Therapy Revenue in 2022
Figure 8. By Type - Global Rheumatoid Arthritis Stem Cell Therapy Revenue Market Share, 2018-2035
Figure 9. By Application - Global Rheumatoid Arthritis Stem Cell Therapy Revenue Market Share, 2018-2035
Figure 10. By Type - Global Rheumatoid Arthritis Stem Cell Therapy Revenue, (US$, Mn), 2022 & 2035
Figure 11. By Type - Global Rheumatoid Arthritis Stem Cell Therapy Revenue Market Share, 2018-2035
Figure 12. By Application - Global Rheumatoid Arthritis Stem Cell Therapy Revenue, (US$, Mn), 2022 & 2035
Figure 13. By Application - Global Rheumatoid Arthritis Stem Cell Therapy Revenue Market Share, 2018-2035
Figure 14. By Region - Global Rheumatoid Arthritis Stem Cell Therapy Revenue Market Share, 2018-2035
Figure 15. By Country - North America Rheumatoid Arthritis Stem Cell Therapy Revenue Market Share, 2018-2035
Figure 16. US Rheumatoid Arthritis Stem Cell Therapy Revenue, (US$, Mn), 2018-2035
Figure 17. Canada Rheumatoid Arthritis Stem Cell Therapy Revenue, (US$, Mn), 2018-2035
Figure 18. Mexico Rheumatoid Arthritis Stem Cell Therapy Revenue, (US$, Mn), 2018-2035
Figure 19. By Country - Europe Rheumatoid Arthritis Stem Cell Therapy Revenue Market Share, 2018-2035
Figure 20. Germany Rheumatoid Arthritis Stem Cell Therapy Revenue, (US$, Mn), 2018-2035
Figure 21. France Rheumatoid Arthritis Stem Cell Therapy Revenue, (US$, Mn), 2018-2035
Figure 22. U.K. Rheumatoid Arthritis Stem Cell Therapy Revenue, (US$, Mn), 2018-2035
Figure 23. Italy Rheumatoid Arthritis Stem Cell Therapy Revenue, (US$, Mn), 2018-2035
Figure 24. Russia Rheumatoid Arthritis Stem Cell Therapy Revenue, (US$, Mn), 2018-2035
Figure 25. Nordic Countries Rheumatoid Arthritis Stem Cell Therapy Revenue, (US$, Mn), 2018-2035
Figure 26. Benelux Rheumatoid Arthritis Stem Cell Therapy Revenue, (US$, Mn), 2018-2035
Figure 27. By Region - Asia Rheumatoid Arthritis Stem Cell Therapy Revenue Market Share, 2018-2035
Figure 28. China Rheumatoid Arthritis Stem Cell Therapy Revenue, (US$, Mn), 2018-2035
Figure 29. Japan Rheumatoid Arthritis Stem Cell Therapy Revenue, (US$, Mn), 2018-2035
Figure 30. South Korea Rheumatoid Arthritis Stem Cell Therapy Revenue, (US$, Mn), 2018-2035
Figure 31. Southeast Asia Rheumatoid Arthritis Stem Cell Therapy Revenue, (US$, Mn), 2018-2035
Figure 32. India Rheumatoid Arthritis Stem Cell Therapy Revenue, (US$, Mn), 2018-2035
Figure 33. By Country - South America Rheumatoid Arthritis Stem Cell Therapy Revenue Market Share, 2018-2035
Figure 34. Brazil Rheumatoid Arthritis Stem Cell Therapy Revenue, (US$, Mn), 2018-2035
Figure 35. Argentina Rheumatoid Arthritis Stem Cell Therapy Revenue, (US$, Mn), 2018-2035
Figure 36. By Country - Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Revenue Market Share, 2018-2035
Figure 37. Turkey Rheumatoid Arthritis Stem Cell Therapy Revenue, (US$, Mn), 2018-2035
Figure 38. Israel Rheumatoid Arthritis Stem Cell Therapy Revenue, (US$, Mn), 2018-2035
Figure 39. Saudi Arabia Rheumatoid Arthritis Stem Cell Therapy Revenue, (US$, Mn), 2018-2035
Figure 40. UAE Rheumatoid Arthritis Stem Cell Therapy Revenue, (US$, Mn), 2018-2035
Figure 41. Mesoblast Rheumatoid Arthritis Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Roslin Cells Rheumatoid Arthritis Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Regeneus Rheumatoid Arthritis Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. ReNeuron Group Rheumatoid Arthritis Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. International Stem Cell Corporation Rheumatoid Arthritis Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Takeda Rheumatoid Arthritis Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
